Naples Women’s Center Obstetrics

In-Office 4-D Ultrasound

3D ultrasound is a medical ultrasound technique, often used in obstetric ultrasonography (during pregnancy), providing three-dimensional images of the fetus. Three-dimensional ultrasound, also known as phased array ultrasonics, is used extensively in the non-destructive evaluation of materials for purity and failure assessment. There are several different scanning modes in medical and obstetric ultrasound. The standard common obstetric diagnostic mode is 2D scanning. In 3D fetal scanning, however, instead of the sound waves being sent straight down and reflected back, they are sent at different angles. The returning echoes are processed by a sophisticated computer program resulting in a reconstructed three-dimensional volume image of the fetus’s surface or internal organs, in much the same way as a CT scan machine constructs a CT scan image from multiple x-rays.

Clinical use of this technology is an area of intense research activity especially in fetal anomaly scanning but there are also popular uses that have been shown to improve fetal-maternal bonding. 4D fetal ultrasounds are similar to 3D scans, with the difference associated with time: 4D allows a 3-dimensional picture in real time, rather than delayed, due to the lag associated with the computer constructed image, as in classic 3-dimensional ultrasound.

Non-Invasive Genetic Testing (NIPT)

The MaterniT® 21 PLUS laboratory-developed test can tell you if you are having a boy or a girl, and screens for both common and rare chromosomal abnormalities. The test screens for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and many other conditions that can affect your baby’s health.

MaterniT 21 PLUS is a laboratory-developed test developed, validated and performed exclusively by Sequenom Laboratories. The test has not been cleared or approved by the US Food and Drug Administration (FDA). Although laboratory-developed tests to date have not been subject to US FDA regulation, certification of the laboratory is required under the Clinical Laboratory Improvement Amendments (CLIA) to ensure the quality and validity of test results. Sequenom Laboratories is CAP accredited and certified under CLIA as qualified to perform high complexity clinical laboratory testing. While the results of the MaterniT 21 PLUS test are highly accurate, discordant results may occur. This test is a screening test and not diagnostic; it does not replace the accuracy and precision of prenatal diagnosis with CVS or amniocentesis. A patient with a positive test result should be referred for genetic counseling and offered invasive prenatal diagnosis for confirmation of test results. A negative test result does not ensure an unaffected pregnancy. Testing could lead to the potential discovery of both fetal and maternal genomic abnormalities that could have major, minor, or no, clinical significance. The ability to report results may be impacted by maternal BMI, maternal weight, maternal systemic lupus erythematosus (SLE) and/or by certain medications such as low molecular weight heparin (for example: Lovenox®, Xaparin®, Clexane® and Fragmin®). The results of this testing, including the benefits and limitations, should be discussed with a qualified healthcare provider. Pregnancy management decisions, including termination of the pregnancy, should not be based on the results of this test alone. Please visit www.sequenom.com for the complete test limitations and our notice of privacy practices

Contraceptive Management

Your contraceptive plan is a very personal decision and the providers at Naples Women’s Center can assist you in making the right choice for you. Whether it is hormonal birth control in the form of pills or shots, Interuterine Devices (IUD), or Essure, we can provide the care you need.